The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016
Open accessAbstract
STUDY QUESTION: What is the current status of assisted reproductive technology (ART) service availability, efficacy and safety in mainland China? SUMMARY ANSWER: In this first national report on ART status in mainland China, data on treatment numbers, outcomes and complications in 2016 are provided and analyzed, respectively. WHAT IS KNOWN ALREADY: National ART Service Provision Surveys are conducted in mainland China regularly. Data were analyzed, and this manuscript was written by team members from the National Center for Women and Children’s Health, China CDC and the Department of Women and Children Health, National Health Commission of the People’s Republic of China. STUDY DESIGN, SIZE AND DURATION: A cross-sectional nationwide survey was completed in 2018, in which data regarding ART treatments, performed from 1st January to 31st December2016 in 445 ART clinics located in 31 provinces of mainland China, were collected. PARTICIPANTS/MATERIALS, SETTING AND METHODS: There were in total 451 licensed ART clinics (including artificial insemination clinics) in mainland China in 2016, of which 445 submitted service data. A total of 906 840 cycles were provided by 323 in vitro fertilization (IVF) clinics, involving 375 770 conventional IVF cycles, 154 948 intracytoplasmic sperm injection (ICSI) cycles, 367 146 frozen embryo transfer (FET) thawing cycles and 8976 preimplantation genetic diagnosis (PGD) treatment cycles. A total of 161 376 artificial (i.e. intrauterine) insemination (AI) cycles were reported by 443 clinics, with 126 872 cycles using the husband’s semen (AIH) and 34 504 using donor semen (AID). MAIN RESULTS AND THE ROLE OF CHANCE: In total, 98.7% of the licensed clinics, contributing to 100% of the ART services (including AID and AIH cycles), were included in this report. (Six clinics provided institutional information only and were excluded.) There were 906 840 in vitro fertilization cycles performed in mainland China with a population of over 1.3 billion inhabitants, with cycles per million inhabitants (C/M) increasing from 360 in 2013 to 657 in 2016, nationwide (range among provinces: 45–3676). After treatment with conventional IVF, the clinical pregnancy rate (PR) per oocyte retrieval cycle was 23.2%, the delivery rate (DR) per oocyte retrieval cycle was 18.7% and the proportion of twin delivery among the total deliveries was 27.9%. For ICSI cycles, the PR, DR and TDR were 20.5%, 16.7% and 27.2%, respectively. For FET per thawing cycles, the PR, DR and TDR were 48.2%, 37.6% and 24.2%. For PGD per diagnosis cycles, the PR, DR and TDR were 38.1%, 29.7% and 4.2%. For AIH cycles, the PR and DR were 13.3% and 10.5%; for AID cycles, the PR and DR were 24.3% and 21.1%, respectively. The total number of live infants born in mainland China in 2016, was 18.46 million, and the number of infants born through ART conducted in 2016 was 311 309, which accounted for 1.69% of the total. The reported rate of birth defects was about 87/10 000. The incidence of moderate to severe ovarian hyper-stimulation syndrome (OHSS) was 11.5 per 1000 oocyte retrieval cycles, and other complications were much more rare. LIMITATIONS AND REASONS FOR CAUTION: This report is based on the summary data of ART services provided. The success rates were not calculated by age stratification. A low rate of birth defects was reported, which might be confounded by variations in birth follow-up methods, statistical timing and record taking. WIDER IMPLICATIONS OF THE FINDINGS: ART service availability has improved significantly in recent years in mainland China. Because China is a vast country, significant imbalances in ART service provision do exist; however, the main efficacy and safety indicators were close to those of western countries. TRIAL REGISTRATION NUMBER: N/A STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Key R&D Program of China (2016YFC1000307–2). There are no competing interests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIRTH AFTER THE REIMPLANTATION OF A HUMAN EMBRYO
Steptoe, P. C., & Edwards, R. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92957-4 · Cited by 2,614
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320
ART in Europe, 2014: results generated from European registries by ESHRE†
De Geyter, C., Calhaz-Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., Goossens, V, et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey242 · Cited by 639
Zegers-Hochschild, F., Mansour, R., Ishihara, O., Adamson, G. D., de Mouzon, J., Nygren, K. G., & Sullivan, E. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.005 · Cited by 540
Dyer, S., Chambers, G. M., de Mouzon, J., Nygren, K. G., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Adamson, G. D. (2016) · Human Reproduction · doi:10.1093/humrep/dew082 · Cited by 491
Adamson, G. D., de Mouzon, J., Chambers, G. M., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Dyer, S. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.039 · Cited by 385
Assisted Reproductive Technology Surveillance — United States, 2015
Sunderam, S., Kissin, D. M., Crawford, S. B., Folger, S. G., Boulet, S. L., Warner, L., & Barfield, W. D. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6703a1 · Cited by 210
Assisted Reproductive Technology Surveillance — United States, 2016
Sunderam, S., Kissin, D. M., Zhang, Y., Folger, S. G., Boulet, S. L., Warner, L., Callaghan, W. M., & Barfield, W. D. (2019) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6804a1 · Cited by 182
Irahara, M., Kuwahara, A., Iwasa, T., Ishikawa, T., Ishihara, O., Kugu, K., Sawa, R., Banno, K., & Saito, H. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12014 · Cited by 133
Assisted reproductive technology in China: compliance and non-compliance.
Qiao, J., & Feng, H. L. (2014) · PubMed · doi:10.3978/j.issn.2224-4336.2014.01.06 · Cited by 114
Research works printed but not linked: 1
- Wang, 2016, The time and space differences of China's agricultural structure characteristics of the carbon emissions and study, The World of Survey and Research, 9, 3
Cited by
Items 101–150 of 150
Li, S., Long, Y., Wang, C., Yang, R., Lv, J., Chen, Z., Liu, J., Liu, H., & Cao, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1441796 · Cited by 2
Liu, J., Dai, Y., Song, Z., Sun, X., Lv, D., & Zhao, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1590261 · Cited by 2
Self-citationZhao, D. P., Zhao, G., Fan, J., Chen, H., Lopriore, E., & Li, X. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06014-w · Cited by 2
The experience of in vitro fertilization data collection in Turkey
Işıkoğlu, M., & de Mouzon, J. (2021) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.galenos.2021.2020.0222 · Cited by 1
“Recently China presented assisted reproductive technology (ART) data for the first time, showing that nearly one-third of all global cycles were performed in mainland China (9).”
BackgroundZhang, J., Deng, K., Mao, X., & Wu, L. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104973 · Cited by 1
Lin, J., Chen, Q., He, Y., Yin, M., & Zhu, Q. (2025) · Human Reproduction · doi:10.1093/humrep/deaf131 · Cited by 1
Jiang, L., Huang, H., Zhou, J., Li, Y., Zhou, Y., & Qian, K. X. (2025) · Reproductive Health · doi:10.1186/s12978-025-02166-z · Cited by 1
Su, M., Cong, H., Nie, H., Li, C., Feng, Y., & Xu, C. (2025) · BMC Public Health · doi:10.1186/s12889-025-25530-x · Cited by 1
“In China, where traditional cultural expectations around fertility are deeply ingrained [3, 4], ART is one of the few viable options for infertile couples [5].”
Mak, W. Y., Alifu, M., Zheng, A., Jia, N., He, Q., Zhu, X., Mao, X., & Xiang, X. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70174 · Cited by 1
“8 While advancements in IVF and FET have improved conception rates, pregnancy loss remains a persistent challenge.”
Zhang, J., Qiu, S., Mao, X., Chen, Y., & Wu, L. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03795-w · Cited by 1
Huang, T., Wang, X., Wang, J., Wu, Y., Zheng, Y., Liu, Y. F., Dang, J., Cai, S. L., Li, J., & Song, Y. (2026) · China Population and Development Studies · doi:10.1007/s42379-026-00217-x · Cited by 1
“The advancement of assisted reproductive technologies can not only help bridge this specific aspect of the fertility gap but also contribute to a more accommodating and supportive reproductive environment for all women (Bai et al., 2020; Li et al., 2019; Qiao et al., 2021).”
Bir üniversite hastanesi’nin intrauterin inseminasyon deneyimi: Gebelik oranı ve ilişkili faktörler
Ateş, E., Akdağ, A., Kol, A., Turan, Ö. D., & Erol, H. (2021) · Androloji Bülteni · doi:10.24898/tandro.2021.85619 · Cited by 1
Associations between vaginal flora, MIP‐1α, IL‐17A, and clinical pregnancy rate in AIH
Yang, H., Gao, C., Wang, X., Qiu, F., Wei, M., & Xia, F. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13543 · Cited by 1
Fan, Y., Wang, Y., Luo, Z., Xu, Y., Zhang, J., Wang, W., Cui, N., & Hao, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.884972 · Cited by 1
Self-citationA novel tube for sperm density gradient centrifugation procedure
Xue, Y., Du, W., Deng, C., Xu, Y., Liu, C., Yang, Y., Wang, L., Lv, Y.-Z., Li, Z., & Chian, R. (2023) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000068 · Cited by 1
“Approximately 2%–6% of infants are born after ARTs [1,2] .”
BackgroundSelf-citationCao, M., You, D., Li, S., Wu, Y., Liu, H., Huang, Q., & Liu, J. (2020) · doi:10.21203/rs.3.rs-44933/v1
Cao, M., Liu, Z., Li, S., Wu, Y., Liu, H., Huang, Q., & Liu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-774823/v1
Martínez-Granados, L., Cuevas, I., Prados, F. J., Pons, I., de Andrés, M., Sánchez-Castro, L., Lafuente, R., Santos, M. J. D. L., Herrero, J., Cabello, Y., et al. (2022) · Medicina Reproductiva y Embriología Clínica · doi:10.1016/j.medre.2022.100117
Current Applications of Machine Learning in Medicine: ART
Swearman, H., Lambert, J. F., & Tran, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-1223-8_6
The number of day 2 4-cell embryos is link with available blastocysts and live birth ratePreprint
Liu, S., Chen, S., Wang, F., Lan, Y., Li, F., Huang, G., Liu, Y., Liu, L., & Zhang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1800695/v1
Tawfeeq, F. M. M., Jwad, M. A., & Reshan, R. G. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.12398
“The ultimate goal of all these procedures is to get a viable intrauterine pregnancy as a step to get a healthy baby (Bai et al., 2020).”
BackgroundProgress in Human Assisted Reproductive Technology and Evaluation of Health Status of Offspring
刘, 晓. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.1291188
Early prenatal diagnosis of acardiac anomaly: A triplet case report
Zhu, Z. (2023) · Sonography · doi:10.1002/sono.12363
Ma, Y., Bai, F., Gao, L., Zhang, Y., & Li, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3151610/v1
Self-citationElective single versus double blastocyst-stage embryo transfer in women aged 36 years or olderPreprint
Cai, H., Shi, J., Mol, B. W., Gordts, S., & Wang, H. (2024) · doi:10.22541/au.170666988.82407219/v1
Yang, Y., Liu, T., Gui, Q., Lan, X., Xiong, J., Luo, S., Zhang, C., Ya, C., & Wang, L. (2024) · Research Square · doi:10.21203/rs.3.rs-4711800/v1
Self-citationZhang, J., Liu, S., Lan, Y., Chen, S., Wan, Y., & Wang, F. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15977
“10 The primary factor determining twinning is the transfer of two embryos.”
Xiong, W., Liang, Q., Han, X., Cheng, Q., Liu, Q., Zuo, X., Wang, H., He, H., & Shan, G. (2025) · Annals of Medicine · doi:10.1080/07853890.2024.2445183
“At present, the number of ART cycles has exceeded one million per year in China, accounting for ∼ 3% of the total number of ART cycles in globe and in 2016, 311,309 ART-conceived children were born, accounting for 1.69% of the total in mainland China [14].”
InfluentialTu, B., Wang, Z., Yang, S., Chen, L., Wang, Y., Yang, R. J., Huang, S., Liu, P., Li, R., & Qiao, J. (2025) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2025.104877
Development and application of vibrating dynamic culture system for mouse oocytes and embryos
Liu, Q., Zhao, S., Zhou, J., Shi, Y., Ye, C., & Huo, B. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1606746
“This static culture method results in weak developmental potential, leading to an implantation rate of only 30% − 40% (10).”
The Correlation Study of Gut Microbiota and Its Metabolites with ART Pregnancy Outcomes
任, 士. (2025) · Medical Diagnosis · doi:10.12677/md.2025.154054
Zhang, Q., Wang, J., Li, T., Wang, X., & Geng, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1614206
Lu, Y., Mao, X., He, Y., Wang, Y., & Sun, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25919100
Wei, J., Luo, Z., Dong, X., Jin, H., Zhu, L., & 艾继辉 (2023) · Figshare · doi:10.6084/m9.figshare.24628036
Lu, Y., Mao, X., He, Y., Wang, Y., & Sun, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25918965
Yang, R., Zhang, Y., Liang, X., Song, X., Wei, Z., Liu, J., Yang, Y., Tan, J., Zhang, Q., Sun, Y., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21273847
He, M., Sun, X., Wang, C., & Sui, Y. (2022) · Figshare · doi:10.6084/m9.figshare.20175838
Bio-inspired DMSO-free ice controlling strategy for the cryopreservation of oocytes
Liu, S., He, X., Qu, J., Wang, N., Chen, X., Han, C., Jin, S., Wang, J., Yan, J., & Qiao, J. (2026) · Fundamental Research · doi:10.1016/j.fmre.2025.12.035
Zou, X., Jalloh, M. A., Wang, Z., Zong, Y., Jiang, Y., Jiang, T., You, L., Qin, R., Lv, H., Liu, Y., et al. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08409-z
“Infants conceived through assisted reproductive technology (ART) account for approximately 2% of live births [1, 2].”
Du, Y., & Talib, A. A. A. (2025) · Journal of Disease and Public Health · doi:10.71052/jdph/yyjt2332
Hu, F., Zhu, H., Fang, J., Li, B., & Xie, D. (2026) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2026.2658942
Wang, R., Yang, H., Ye, H., Yan, L., Shi, L., Jiwen, Z., Zhang, C., Liu, Y., Yao, K., Sun, L., et al. (2026) · Cryobiology · doi:10.1016/j.cryobiol.2026.105644
Fang, Q.-Y., Gan, D.-H., Chen, R.-Y., Zhu, K.-H., Huang, J., & Lian, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08411-8
“Despite advancements in assisted reproductive technology (ART), the success rates remain suboptimal, with approximately 50–60% of IVF cycles failing to achieve implantation [3, 5, 6].”
Konaté, M., Traore, A., Ganmenon, M., Kassogue, J., Sissoko, M., Coulibaly, Z., Wida, L., Dourra, M., Diarra, A., Nouhoeflin, J., et al. (2026) · SAS Journal of Medicine · doi:10.36347/sasjm.2026.v12i06.014
Bo, Z., Zou, K., Li, H., Jiang, Y., Zeng, L., Tang, Y., Zhao, S., Jiang, Y., & Zhang, L. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1818893
“In 2016, the number of infants born through assisted reproductive technology accounted 1.69% of the total livebirths and showed an upward trend in China (55).”
InfluentialA large-scale prediction model to predict large for gestational age infants conceived by IVF/ICSI
Li, X., Zhang, A., Bai, G., Liu, Y., Xing, W., & Li, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1842531
Wang, Y., Xu, C., He, Y., Huang, J., Sun, Y. X., Lu, Y., & Wei, Z. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145544
“In vitro fertilization–embryo transfer (IVF-ET) is an established treatment for infertility and has been increasingly used worldwide [1–3].”
Lan, K., Yin, S., Wang, Y., Li, R., Zhao, Y., Wei, Y., Chen, S., & Li, Z. (2026) · Reproductive Health · doi:10.1186/s12978-026-02406-w
“A national cross-sectional study using data of 1 211 303 cycles and 47 725 infants over 4 years in China, the number of infants born through IVF-ET accounted 1.69% of the total number of livebirths [20].”
InfluentialExploring post-traumatic growth in women experiencing infertility: levels and mechanisms
Niu, C., Yu, Y., Xie, Y., Yang, F., Ma, S., Lu, X., Xiao, C., Gao, Y., Shen, N., Zhu, W., et al. (2026) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2026.105919
Shang, X., Gao, R., Zhang, X., Zhao, F., Du, J., Qi, Y., Liu, M., Li, P., Liu, J., Zhao, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11151221/v1
Metadata
- Authors
- Bai, F., Wang, D. Y., Fan, Y. J., Qiu, J., Wang, L., Dai, Y., & Song, L.
- Affiliations
- National Center for Women and Children’s Health, China CDC (CN)
- National Health and Family Planning Commission (CN)
- Corresponding author
- Song, L
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02
- Volume
- 35
- Issue
- 2
- Pages
- 446-452
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W3004948551
- Cited by
- 150
- References
- 12
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 23 · 2023: 27 · 2022: 33 · 2021: 23 · 2020: 9
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development of China (2016YFC1000307–2)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- assisted reproduction, in vitro fertilization, intracytoplasmic sperm injection, frozen embryo transfer, preimplantation genetic diagnosis, artificial insemination, ART outcomes, mainland China, ART regulation, infertility treatment
- MeSH terms
- Child, China, Cross-Sectional Studies, Female, Fertilization in Vitro, Humans, Pregnancy, Pregnancy Outcome, Registries, Pregnancy Rate, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.